Raiffeisen Bank International’s Atara Biotherapeutics ATRA Stock Holding History

Raiffeisen Bank International’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.3K	Hold	200	–	–	﹤0.01%	761
2026 Q1	$946	Hold	200	–	–	﹤0.01%	809
2025 Q4	$3.01K	Hold	200	–	–	﹤0.01%	771
2025 Q3	$2.87K	Buy	+200	New	+$2.3K	﹤0.01%	779

Other funds holding ATRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

KFP

Kerr Financial Planning Fresno, California $89.6M AUM 72.71% 1-Year Est. Return

Raiffeisen Bank International's ATRA Position: Q3 2025 in Review

Raiffeisen Bank International sold out of Atara Biotherapeutics (ATRA) in Q3 2025, closing a stake of 200 shares — an estimated $2.3K sold.

Raiffeisen Bank International first reported a position in ATRA in Q1 2025 and held it in 2 quarters. The position peaked at $1.54K in Q2 2025. 37 funds tracked by Wall St. Rank hold ATRA as of Q3 2025.

Raiffeisen Bank International reported no remaining Atara Biotherapeutics position as of Q3 2025 after selling out during the quarter.
Raiffeisen Bank International sold 200 Atara Biotherapeutics shares in Q3 2025, an estimated $2.3K.
Raiffeisen Bank International first reported a position in Atara Biotherapeutics in Q1 2025 and held it in 2 quarters.
Raiffeisen Bank International's Atara Biotherapeutics position peaked at $1.54K in Q2 2025.
37 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2025.

Based on Raiffeisen Bank International's 13F filing for Q3 2025, filed 10 Nov 2025.